MD Anderson and Accelerator Life Science Partners launch Magnolia Neurosciences

(University of Texas M. D. Anderson Cancer Center) The University of Texas MD Anderson Cancer Center and Accelerator Life Science Partners, a leading life science investment and management firm, today announced the launch of Magnolia Neurosciences Corporation, a company developing a new class of neuroprotective medicines, with $31 million in Series A funding.